272 Capital’s AngioDynamics ANGO Stock Holding History

272 Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-28,078	Closed	-$232K	–	75
2023 Q4	$232K	Hold	28,078	–	–	0.08%	73
2023 Q3	$205K	Buy	+28,078	New	+$234K	0.08%	58

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

272 Capital's ANGO Position: Q1 2024 in Review

272 Capital sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 28,078 shares — an estimated $232K sold.

272 Capital first reported a position in ANGO in Q3 2023 and held it in 2 quarters. The position peaked at $232K in Q4 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

272 Capital reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
272 Capital sold 28,078 AngioDynamics shares in Q1 2024, an estimated $232K.
272 Capital first reported a position in AngioDynamics in Q3 2023 and held it in 2 quarters.
272 Capital's AngioDynamics position peaked at $232K in Q4 2023.
135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on 272 Capital's 13F filing for Q1 2024, filed 15 May 2024.